Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
88 /100
CRITICAL RISK
Score updated Oct 13, 2026

ARTL — Artelo Biosciences, Inc. Dilution Risk Tracker

Track ARTL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARTL — Get alerts when the score changes →

As of October 13, 2026, Artelo Biosciences, Inc. (ARTL) has a DilutionWatch DilutionScore of 88/100, rated CRITICAL dilution risk. Artelo Biosciences, Inc. has a market capitalization of $14.29M, 4.60M shares outstanding, 2 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $75.00M, ATM program capacity of $31.40M, 4.43B outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
65
📊 Float Risk
57
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 48%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 96482% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 53%
• Under 12 months cash (6mo)
• Active shelf registration ($75M, 525% of market cap)
📉 Score Deterioration model 15%
• Score already CRITICAL (88/100) — events likely imminent
🔔 Track ARTL — Get forecast alerts →

Market Data

Market Cap$14.29M
Shares Outstanding4.60M
Float2.12M
Cash$4.20M
Debt$719.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore88/100DilutionWatch score record
Shares Outstanding4.60MVerified float table or market cache
Public Float2.12MVerified float table or market cache
Market Cap$14.29MMarket data cache
Cash Runway6.4 monthsDilutionWatch score inputs
Shelf Capacity$75.00MSEC-derived dilution fields
ATM Capacity$31.40MSEC-derived dilution fields
Outstanding Warrants4.43BSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 2, S-3 1, SC 13G/A 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 98.0% shares (2026Q1 vs prior)
2 institutional holders · 2.0K shares
#1 MORGAN STANLEY 1.1K shares
#2 Altshuler Shaham Ltd 889 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest46.2K
Days to Cover1.0
% of Float2.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-08-12
xbrl XBRL WARRANT 2026-05-14
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-13
4 INSIDER TRANSACTION 2026-07-21
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ARTL Dilution Snapshot

Artelo Biosciences, Inc. (ARTL) has a DilutionScore of 88/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ARTL's DilutionScore is currently 88/100 (Critical risk), with 2 score changes tracked over 89 days. The score improved from 82/100 (Critical risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202688/100CRITICAL53 days
Aug 14 – Aug 21, 202682/100CRITICAL7 days
Jul 16 – Aug 13, 202675/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ARTL shares outstanding have increased 167.1% from 817.1K (Apr 2026) to 2.18M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 17, 20262.18M2.12M▲ 229.48%
Apr 20, 2026938.1K644.7K▲ 1.89%
Apr 07, 2026817.1K632.7K▼ 10.26%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ARTL Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ARTL files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ARTL — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ARTL
ARTL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.